Summary Proceedings of AGM

C8> CONCORD DRUGS LIMITED Regd. Office & Factory : Survey No. 249, Brahmanapally Village, Hayathnagar Mandal, R.R. Dist. - 501 511. (T.S) INDIA. Admin Office : 3-11-451, L B Nagar, Hyderabad - 500074 E-mail : concorddrugsltd@gmail.com Ph.No : +91 9052779505 Web: wwsw.coincortddruegs. in Date: 30.09.2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal St, Fort, Mumbeai, Maharashtra 400001. Scrip Code: 538965 Subject: 31+t Annual General Meeting (AGM) for financial year 2025-26: With reference to the subject cited above, this is to inform the Exchange that 31t Annual General Meeting for the financial year 2025-26 of Concord Drugs Limited was held on Wednesday, 30.09.2026 at 09.30 a.m. through Video Conference. In this regard, please find enclosed Summary proceedings as required under Regulation 30, Part-A of Schedule -III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Meeting was concluded at 09:50 a.m. This is for the information and records of the exchange, please. Thanking you Yours Sincerely, Digitally signed SEELAM by SEELAM For Concord Drugs Limited MANOJ MANOJ KUMAR KUMAR ReDDY Date: 2026.09.30 REDDY 15:35:08-+05'30" MANO]J KUMAR REDDY SEELAM Director (DIN: 06991382) Encl: as above C8> CONCORD DRUGS LIMITED Regd. Off& iFacctoery : Survey No. 249, Brahmanapally Village, Hayathnagar Mandal, R.R. Dist. - 501 511. (T.S) INDIA. Admin Office : 3-11-451, L B Nagar, Hyderabad - 500074 E-mail : concorddrugsitd@gmail.com Ph.No : +91 9052779505 Website : www.concorddrugs.in To, Date: 30.09.2026 BSE Limited P.]. Towers, Dalal Street, Mumbai - 400001 Dear Sir/ Madam, Subject: Summary of Proceedings of 31st Annual General Meeting for the financial year 2025- 26 held on 30.09.2026 as required under Regulation 30, PART —A of the schedule III of the SEBI (Listing Obligations and Disclosure Requirements), 2015 Scrip Code: 538965. Summary of proceedings of the Annual General Meeting: The 31st Annual General Meeting ("AGM”) of the members of Concord Drugs Limited (“the Company”) for the financial year 2025-26 was held on Wednesday, September 30, 2026 at 09.30 a.m. (IST) through video conferencing and other audio-visual means (“VC"). The meeting was held in compliance with the General Circulars issued by the Ministry of Corporate Affairs (MCA) and circulars issued by the Securities and Exchange Board of India (SEBI) and as per the applicable provisions of the Companies Act, 2013 and the Rules made thereunder. Directors and KMPs present (all present through VC / at Registered Office) SL.No Name Designation 1 S. Nagi Reddy Chairman & Managing Director 2 S. Koni Reddy Whole-Time Director & CFO 3 S. Manoj Kumar Reddy ‘Whole-Time Director 4 Gopidi Reddy Independent Director 5 Nagavenkata Hareesh Kumar Solleti | Independent Director 6 Sumeela Kasu Independent Director 7 Namratha Nagla Company Secretary & Compliance Officer Other invitees in attendance SLNo Name Designation 1 P Srikant Kumar Scrutinizer (PSK & Associates) Quorum A total of 63 members attended the meeting through VC. The meeting commenced at 09:30 am. and concluded at 09:50 a.m. Page 1of3 Summary Proceedings of the Meeting: Mr. Manoj Kumar Reddy, Whole-Time Director chaired the meeting. He extended a warm welcome to all the members, fellow Board members and other invitees attending the meeting. He has given a brief about the performance of the company to the shareholders of the company and review of insights about future operations. On ascertaining that the requisite quorum being present, it was confirmed to the shareholders that the Company had taken all feasible efforts under the current circumstances to enable members to participate through VC and vote on the items being considered for the meeting. It was informed that the Company provided the Members the facility to cast their vote electronically on the resolutions set forth in the Notice. Members who were present at the AGM and had not cast their votes through remote e-voting were provided an opportunity to vote electronically at the AGM. Further, Agenda was proceeded with and it was informed to the members about the procedure to be followed for e-voting at the AGM and the agenda items were read for the information of members as per the Notice of AGM: SL.No | Description of Resolutions | Type of resolution Ordinary Business 1 To Receive, Consider and Adopt the Audited | Ordinary Standalone and Consolidated Financial Statements for FY 2025-26 2 To Appoint a Director in Place of Mr. S. Nagi | Ordinary Reddy, Who Retires by Rotation And, Being Eligible, Offers Himselfofr Re-Appointment. 3 Re-Appointment of Statutory Auditors For | Ordinary Second Term of Five Consecutive Years Special business 4 To Approve the Related Party Transactions | Ordinary to Be Entered for The Financial year 2026- 5 Ratification of Payment of Remuneration Of | Ordinary M/s. KJU & Associates, Cost Auditors of The Company for The Financial Year 2026-2027 6 Re-Appointment of Mr S. Nagavenkata | Special Hareesh Kumar Solleti (Din: 09066790) as an Independent Director 7 Re-Appointment of Ms. Sumeela Kasu (Din: | Special 09571540) as an Independent Director Since, all the Resolutions have been already put to vote through remote e-voting, there was no proposing and seconding of the Resolutions and no voting by show of hands. Members were then provided with a facility to ask questions or express their views through VC. The Board of Directors had appointed Mr. P Srikant Kumar, proprietor of PSK & Associates, Practicing Company Secretaries as the Scrutinizer to scrutinize the process for remote e-voting & e-voting at AGM. The Scrutinizer will submit the report on remote e-voting and e-voting at the AGM and the same will be placed on the Company’s website and forwarded to BSE Limited within the prescribed time. Page 20f3 It was informed that opening of e-Voting at the AGM for the members who had not already casted their vote by means of remote e-voting, which was made available by CDSL from the conclusion of the AGM. Further, it was informed to the shareholders that the results of e-voting shall be disseminated to BSE Limited as soon as possible and the same will be placed on the website of the Company. The meeting concluded at 09:50 a.m. with vote of thanks to all the members. Thanking you. SEELAM Digitally signed Yours sincerely, MANOJ b y wiSaEnEoLAsMk.U mar For Concord Drugs Limited REDDY KUMAR Date: 2026.09.30 REDDY 15:3214 40530 Seelam Manoj Kumar Reddy Director (DIN: 06991382) Page 30f3